I have, and it tells me the following: after about 2 decades of...

I have, and it tells me the following: after about 2 decades of tinkering this company is saying:
1. We’ve shown some interesting “unique” immunological changes when used with SOC ART in HIV in phase 2, hypothesis generating I think is the term, but nothing else yet and after 2 decades we don’t know if our compound will add any efficacy over ART.
2. We think we could be effective in HBV but we have nothing but that nothingness looks promising anyway
3. we’ve given up on HCV because we’ve taken so long and the DAAs stormed in and took the market
4. We tried to crack SARS Cov-1 from 2003, got nowhere but it’s still really promising
5. We’ve been screening assets for SARS Cov 2 since February, found nothing but it’s still looking really promising.
6. We’ve hired a CMO (small print- part time consultancy basis)

is that about it?